Key result
PVAI ablation achieved control of any AF or atrial tachycardia off drugs in 72% of patients compared to 57% with CFE ablation (P=0.075), and had a lower recurrence rate of AT (11.9% vs 34.5%, P=0.004).
Why the study?
Does PVAI ablation improve control of AF/AT off drugs compared to CFE ablation in patients with drug-refractory paroxysmal atrial fibrillation?
RCT (n=118)
randomized
Does PVAI ablation improve control of AF/AT off drugs compared to CFE ablation in patients with drug-refractory paroxysmal atrial fibrillation?
Absolute Event Rate: 72% vs 57%
p-value: p=0.075
PVAI ablation is superior to CFE ablation alone for paroxysmal AF, as CFE ablation is associated with a higher rate of post-procedure atrial tachycardia.
PVAI ablation did not significantly improve AF/AT control versus CFE (P=0.075); extends evidence against CFE due to higher AT recurrence.
INTRODUCTION: Circumferential pulmonary vein antral isolation (PVAI) and atrial complex fractionated electrograms (CFEs) are both ablative techniques for the treatment of paroxysmal atrial fibrillation (PAF). However, data on the comparative value of these 2 ablation strategies are very limited. METHODS AND RESULTS: We randomized 118 patients with drug-refractory PAF to receive PVAI ablation (n = 60) or CFE ablation (n = 58). For CFE group, spontaneous/induced AF was mapped using validated, automated software to guide ablation until all CFE areas were eliminated. For PVAI group, all 4 pulmonary vein antra were electrically isolated as confirmed by circular mapping catheter. Patients with spontaneous/inducible AF after the initial ablation procedure were crossed over to the other arms. After initial ablation procedure, AF persisted/inducible in 24/59 patients (41%), and 34/58 patients (59%) assigned to PVAI and CFE ablation, respectively (P = 0.05). Then 58 patients underwent PVAI + CFE ablation. After 22.6 ± 6.4 months, PVAI ablation group was more likely than CFE ablation group to achieve control of any AF/atrial tachycardia (AT) off drugs (43/60, 72% vs 33/58, 57%, P = 0.075) and lower recurrence rate of AT (11.9% vs 34.5%, P = 0.004). Patients who received CFE ablation alone (38%) had significantly lower overall success rate to achieve control of AF/AT off drugs compared with patients who received PVAI ablation (77%, P = 0.002) alone or PVAI + CFE ablation (69%, P = 0.008) due to higher recurrence rate of AT (50% vs 6% vs 13%, P < 0.01). CONCLUSIONS: CFE ablation in PAF patients was associated with higher occurrence rate of postprocedure AT compared with PVAI ablation, whereby making it less likely to be a sole ablation strategy for PAF patients.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2011) conducted an RCT in drug-refractory paroxysmal atrial fibrillation (PAF) (n=118). Pulmonary vein antral isolation (PVAI) ablation vs. Complex fractionated electrogram (CFE) ablation was evaluated on Control of any AF/atrial tachycardia (AT) off drugs (p=0.075). PVAI ablation achieved control of any AF or atrial tachycardia off drugs in 72% of patients compared to 57% with CFE ablation (P=0.075), and had a lower recurrence rate of AT (11.9% vs 34.5%, P=0.004).